TreatSMA builds awareness of spinal muscular atrophy (SMA), a severe neuromuscular disorder and the leading genetic cause of infant death. We support families affected by the disease, promote scientific research into causes and potential treatments, and do everything possible to bring effective therapies to all people with SMA.
| Website | https://www.treatsma.uk |
| Revenue | $3 million |
| Employees | 2 (0 on RocketReach) |
| Founded | 2017 |
| Phone | +44 300 800 0202 |
| Technologies |
JavaScript
,
HTML
,
PHP
+15 more
(view full list)
|
| Industry | Civic and Social Organizations, Hospitals & Clinics, Healthcare |
| Keywords | Spinal Muscular Atrophy, Patient Advocacy, Genetic Research, Family Support, Sma, Disease Research, Healthcare Advocacy, Medical Research, Disease Awareness, Drug Discovery, Nonprofit Organization, Clinical Trials, Infant Mortality, Muscle Weakness, Motor Neuron Disease, Muscular Dystrophy |
| Competitors | Biogen, Sarepta Therapeutics, Inc., Pfizer, Novartis, Roche, Regeneron, Plexium, Stony Brook University, Bristol Myers Squibb, アステラス製薬（株） +34 more (view full list) |
| SIC | SIC Code 80 Companies, SIC Code 86 Companies |
| NAICS | NAICS Code 621 Companies, NAICS Code 62 Companies |
Looking for a particular TreatSMA employee's phone or email?
TreatSMA Questions
The TreatSMA annual revenue was $3 million in 2026.
TreatSMA is based in London, England.
The NAICS codes for TreatSMA are [621, 62].
The SIC codes for TreatSMA are [80, 86].
Related Companies
G2Crowd Trusted
300K+
Plugin Users
